TEVA PHARMACEUTICAL INDUSTRIES LIMITED Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 12.40 million shares for the 12-month period ending 2018-12-31, per its 10-K filed 2021-02-10.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2021-02-10
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2018 was 12.40M shares, a 19.82% decline from fiscal 2017.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2017 was 15.47M shares, a 41.96% increase from fiscal 2016.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2016 was 10.89M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|
| 2018-12-31 | 12.40M shares 10-K · filed 2021-02-10 |
| 2017-12-31 | 15.47M shares 10-K · filed 2020-02-21 |
| 2016-12-31 | 10.89M shares 10-K · filed 2019-02-19 |